Progressive Familial Intrahepatic Cholestasis
📧 Sign up to get email alerts when something new happens for Progressive Familial Intrahepatic Cholestasis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2022-10-21FDA Approved: BYLVAY — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)
The document notes a supplemental application submission for BYLVAY (odevixibat) by Ipsen Biopharmaceuticals, Inc., related to labeling chan…